Immunophage Biotech

China
Shaxi, Fujian, China, 201114

Company profile

Immunophage Biotech company profile

Immunophage Biotech is a Chinese high-tech pharmaceutic company which was established in 2016. The R&D center of the company is located in the Pujiang High-Tech Park, Shanghai, China. They are developing first-in-class immune-regulating medicines against cancer, autoimmune diseases and neurodegenerative disorders.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2016-01-01, Year

Headquarters

Postal code
201114
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$74.5M
Last funding
Series B / $29.2M / 2023-03-13
Last equity funding
Series B / $29.2M
Investors
14
Lead investors
6
Founders
1
Articles
9

Founders and investors

Founders

Fan Guohuang

Lead investors

Jinfang Hongrui Investment ManagementLC VenturesMed-Fine CapitalShanghai Junshi BiosciencesYijing CapitalZhongbo Juli

Investors

Med-Fine CapitalShanghai Junshi BiosciencesTao CapitalYijing CapitalZhongbo Juli